Financial Instruments Owned |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Instruments Owned [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial instruments owned | 6. Financial instruments owned These instruments consist of the following:
The Company recognized net trading losses on financial instruments owned that were still held at the reporting dates of $779 and $545 during the three months ended March 31, 2026 and 2025, respectively, which were recorded in other losses, net, in the Consolidated Statements of Operations. |
|||||||||||||||||||||||||||||||||||||||||||||